CSIMarket
 


Adamas Pharmaceuticals Inc  (ADMS)
Other Ticker:  
 
 

ADMS's Capital Expenditures Growth by Quarter and Year

Adamas Pharmaceuticals Inc's Capital Expenditures results by quarter and year




ADMS Capital Expenditures (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
IV Quarter December - 0.00 0.00 0.00
III Quarter September 0.01 0.00 0.00 1.18
II Quarter June 0.03 0.00 0.01 0.00
I Quarter March 0.00 0.00 0.01 0.50
FY   0.04 0.00 0.02 1.68



ADMS Capital Expenditures third quarter 2021 Y/Y Growth Comment
Adamas Pharmaceuticals Inc in the third quarter 2021 achieved Capital Expenditures of $ 0.01 millions compare to Capital Expenditures recorded in same quarter a year ago.

According to the results reported in the third quarter 2021, Adamas Pharmaceuticals Inc achieved the best Capital Expenditures growth in Major Pharmaceutical Preparations industry. While Adamas Pharmaceuticals Inc' s Capital Expenditures no change of % ranks overall at the positon no. in the third quarter 2021.




ADMS Capital Expenditures ( Y/Y Growth %) 2021
2020 2019 2018
IV Quarter December - - - -
III Quarter September - - - 268.75 %
II Quarter June - - - -
I Quarter March - - -98 % 38.89 %
FY   - - -98.81 % 33.33 %

Financial Statements
Adamas Pharmaceuticals Inc's third quarter 2021 Capital Expenditures $ 0.01 millions ADMS's Income Statement
Adamas Pharmaceuticals Inc's third quarter 2020 Capital Expenditures $ 0.00 millions Quarterly ADMS's Income Statement
New: More ADMS's historic Capital Expenditures Growth >>


ADMS Capital Expenditures (Quarter on Quarter Growth %)

2021
2020 2019 2018
IV Quarter December - - - -
III Quarter September -73.33 % - - -
II Quarter June - - 0 % -
I Quarter March - - - 56.25 %
FY (Year on Year)   - - -98.81 % 33.33 %




Capital Expenditures third quarter 2021 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Capital Expenditures Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Capital Expenditures third quarter 2021 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Capital Expenditures Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Capital Expenditures by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Adamas Pharmaceuticals Inc's Q/Q Capital Expenditures Growth


Capital Expenditures Q/Q Growth Statistics
High Average Low
2283.33 % 137.69 % -100 %
(Jun 30 2015)  


ADMS's III. Quarter Q/Q Capital Expenditures Comment
In the III. Quarter 2021 Adamas Pharmaceuticals Inc disclosed fall in Capital Expenditures from the previous quarter by -73.33% to $ 0.01 millions, from $ 0.03 millions declared a quarter before.

Within Major Pharmaceutical Preparations industry 204 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Adamas Pharmaceuticals Inc's Capital Expenditures growth quarter on quarter, overall rank is 2941.


Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #205
Healthcare Sector #582
Overall #2941
Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #205
Healthcare Sector #582
Overall #2941
Capital Expenditures Q/Q Growth Statistics
High Average Low
2283.33 % 137.69 % -100 %
(Jun 30 2015)  


ADMS's III. Quarter Q/Q Capital Expenditures Comment
In the III. Quarter 2021 Adamas Pharmaceuticals Inc disclosed fall in Capital Expenditures sequentially by -73.33% to $ 0.01 millions, from $ 0.03 millions achived in the previous reporting period.

Within Major Pharmaceutical Preparations industry 204 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Adamas Pharmaceuticals Inc's Capital Expenditures growth quarter on quarter, overall rank is 2941.


Adamas Pharmaceuticals Inc's 12 Months Capital Expenditures Growth Year on Year


Capital Expenditures TTM Growth

12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
12 Months Ending
(Mar 31 2021)
12 Months Ending
(Dec 31 2020)
12 Months Ending
(Sep 30 2020)
Cumulative Capital Expenditures 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Capital Expenditures Growth (TTM) - - - - -
Year on Year Capital Expenditures Growth Overall Ranking # # # # #
Seqeuential Capital Expenditures Change (TTM) - - - - -
Seq. Capital Expenditures Growth (TTM) Overall Ranking # # # # #




Cumulative Capital Expenditures growth Comment
In the Sep 30 2021 period, Adamas Pharmaceuticals Inc's cumulative trailing twelve month Capital Expenditures remained unchanged compare to the same period a year ago.

Adamas Pharmaceuticals Inc achieved highest trailing twelve month year on year Capital Expenditures growth. While overall Capital Expenditures growth ranking, remained unchanged compare to the previous quarter at no. .

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Capital Expenditures growth Comment
In the Sep 30 2021 period, Adamas Pharmaceuticals Inc's cumulative trailing twelve month Capital Expenditures remained unchanged compare to the same period a year ago.

Adamas Pharmaceuticals Inc achieved highest trailing twelve month year on year Capital Expenditures growth. While overall Capital Expenditures growth ranking, remained unchanged compare to the previous quarter at no. .

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Capital Expenditures Growth
Major Pharmaceutical Preparations Industry Capital Expenditures Growth Trends and Statistics
Healthcare Sector Capital Expenditures Growth Statistics
Capital Expenditures Growth Trends for overall market
ADMS's Capital Expenditures Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Capital Expenditures Growth
Lowest Ranking Capital Expenditures Growth
Capital Expenditures Growth for ADMS's Competitors
Capital Expenditures Growth for Adamas Pharmaceuticals Inc's Suppliers
Capital Expenditures Growth for ADMS's Customers

You may also want to know
ADMS's Annual Growth Rates ADMS's Profitability Ratios ADMS's Asset Turnover Ratio ADMS's Dividend Growth
ADMS's Roe ADMS's Valuation Ratios ADMS's Financial Strength Ratios ADMS's Dividend Payout Ratio
ADMS's Roa ADMS's Inventory Turnover Ratio ADMS's Growth Rates ADMS's Dividend Comparisons



Companies with similar Capital Expenditures fall for the quarter ending Sep 30 2021 within Healthcare SectorY/Y Change %Capital Expenditures for the quarter ending Sep 30 2021
Davita Inc -0.01%$ -0.008 millions
National Research Corporation-1.59%$ -1.587 millions
Owens and Minor inc-2.06%$ -2.065 millions
Quest Diagnostics Inc-2.20%$ -2.198 millions
Community Health Systems Inc -2.40%$ -2.400 millions
Alimera Sciences Inc -2.52%$ -2.516 millions
Ptc Therapeutics inc -2.61%$ -2.611 millions
Adma Biologics Inc -3.34%$ -3.342 millions
Neubase Therapeutics inc -3.47%$ -3.467 millions
Arvinas Inc -4.18%$ -4.176 millions
Universal Health Services Inc -4.29%$ -4.286 millions
Global Blood Therapeutics Inc.-4.41%$ -4.412 millions
Inspire Medical Systems inc -5.27%$ -5.267 millions
Avidity Biosciences Inc -5.33%$ -5.325 millions
3m Company-6.79%$ -6.793 millions
Abbott Laboratories-7.06%$ -7.056 millions
Bruker Corporation-7.39%$ -7.386 millions
Retractable Technologies inc -8.17%$ -8.166 millions
Calcimedica Inc -8.63%$ -8.629 millions
Cerus Corporation-8.68%$ -8.678 millions
Mallinckrodt Plc-9.91%$ -9.910 millions
Tivity Health Inc -9.92%$ -9.921 millions
Syneos Health Inc -9.92%$ -9.923 millions
Invacare Holdings Corporation-10.01%$ -10.008 millions
Gilead Sciences Inc -10.32%$ -10.323 millions
Tg Therapeutics Inc -11.24%$ -11.236 millions
Orthofix Medical Inc -11.36%$ -11.358 millions
Si bone inc -11.88%$ -11.875 millions
Orasure Technologies Inc-11.89%$ -11.891 millions
Agile Therapeutics Inc-12.16%$ -12.162 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com